Semuloparin (AVE-5026)

From - A Hematology Oncology Wiki
Jump to navigation Jump to search

General information

Class/mechanism: Hemisynthetic ultra low molecular weight heparin (ULMWH), binds to antithrombin III, accelerating its activity and inhibiting factor Xa, factor IIa, and thrombin.[1]

Route: SC
Extravasation: n/a

Patient drug information

No information available.

Also known as

  • Code name: AVE-5026


  1. Agnelli G, George DJ, Kakkar AK, Fisher W, Lassen MR, Mismetti P, Mouret P, Chaudhari U, Lawson F, Turpie AG; SAVE-ONCO Investigators. Semuloparin for thromboprophylaxis in patients receiving chemotherapy for cancer. N Engl J Med. 2012 Feb 16;366(7):601-9. link to original article PubMed